Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of osteoporosis: opportunities and challenges.

Journal of musculoskeletal & neuronal interactions - 1 Jan 2000

Nguyen T V, Eisman J A

Abstract excerpt

The genetics of osteoporosis can be considered in two broad areas: disease susceptibility and drug activity. While the former has been studied, the latter is still largely untouched. Pharmacogenomics is the utilization of genetic information to predict outcome of drug treatment, with respect to both beneficial and adverse effects. The pharmacotherapy of osteoporosis is characterized by variability in therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density
Share to Genetic Predisposition to Disease
Share to Osteoporosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Source

Identifiers

PMID: 16675890

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of osteoporosis: opportunities and challenges.PMID 16675890Read ↗

Pharmacogenetics of osteoporosis: future perspectives.Semantic proximity Read ↗

An overview of osteoporosis: from genetics to clinics.Semantic proximity Read ↗

Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.Semantic proximity Read ↗

Genetics of osteoporosis from genome-wide association studies: advances and challenges.Semantic proximity Read ↗

Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.Semantic proximity Read ↗

The genetics of osteoporosis. Future diagnostic possibilities.Semantic proximity Read ↗

Genetic factors in osteoporosis. What are the implications for prevention and treatment?Semantic proximity Read ↗

Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.Semantic proximity Read ↗

From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic ApproachesSemantic proximity Read ↗

The genetics of osteoporosis.Semantic proximity Read ↗

Genetic epidemiology of age-related osteoporosis and its clinical applications.Semantic proximity Read ↗

Osteoporosis: A Silent Disease with Complex Genetic Contribution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.